Running both together produces better outcomes than either alone for structural injuries
If you've been using copper peptides daily, drop to every other day or every third day
Topical application primarily affects the epidermis and superficial dermis
Cardiovascular risk2.4mg/wk The dose tested in the cardiovascular outcomes trial, which cut major adverse cardiovascular events by 20% in people with established cardiovascular disease and no diabetes
Chemotherapy-induced peripheral neuropathy CIPN involves direct neurotoxic damage to dorsal root ganglion neurons, primarily through mitochondrial dysfunction, disrupted axonal transport, and neuroinflammation
Published clinical pharmacokinetic studies comparing IM injection sites show that peak plasma concentration (Cmax) values can vary by 1525% between different IM sites for the same compound and dose, making site consistency critical for reproducible subcutaneous vs intramuscular peptide injection research outcomes